Hemorrhage, Postpartum
13
2
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.7%
1 terminated out of 13 trials
87.5%
+1.0% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
Hemophilia A Research Program
CNAP vs IABP in Pregnant Women With Placenta Accreta
Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa
Complications Associated With Intraoperative Hypothermia.
A Pilot Study to Assess the Feasibility and Tolerability of the AccuFlow Perfusion Sensor for Intrapartum Hemorrhage
Fertility After Intrauterine Tamponing Balloon: Where Are we
Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section
Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge
Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery
Scaling Up an Integrated Approach to Improve Delivery Care in North Guatemala With Stepped Wedge Design
Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery
Haemorrhagia Postpartum: an Implementation Study on the NVOG Guidelines and MOET Instructions